What is it about?
Ambulatory high dose methotrexate administration as CNS prophylaxis in non-Hodgkin lymphoma. Improve quality of life optimizing health resources.
Featured Image
Photo by Andreas Klassen on Unsplash
Why is it important?
It shows the results of a study with ambulatory administration of high dose of high risk chemotherapy avoiding hospital addmissions.
Perspectives
Read the Original
This page is a summary of: Experience with ambulatory high-dose methotrexate administration as CNS prophylaxis in patients with non-Hodgkin lymphoma, Journal of Oncology Pharmacy Practice, June 2019, SAGE Publications,
DOI: 10.1177/1078155219852412.
You can read the full text:
Resources
Contributors
The following have contributed to this page